"The medicines which were provided to the affected women at the camps were found to be substandard and traces of poisonous substances were also found in it as per the medical reports," Health Minister Amar Agrawal told reporters here last night.
He said the reports of samples of medicines and viscera have been received from all the laboratories, including Delhi and Kolkata, and were handed over to police for further action.
"All the reports have been received and it is now clear that poison-contaminated medicines caused the deaths of women," he said.
However, the Minister did not specify the kind of poisonous substance and in which medicine it was found.
Agrawal also did not rule out negligence on the part of doctors who conducted the procedure and supervised the camps.
"Doctors had allegedly violated the standard protocol of operation, therefore we can't say that they are not guilty. They operated upon several women together within a short time. They should have taken care of disinfection and cleanliness of the operation theatre and equipments in the camps too," he said.
Medical reports will be further handed over to the state-constituted judicial commission probing the incident and after a thorough probe things will be clearer, he added.
Earlier, Principal Secretary of Health Department Dr Alok Shukla had said that medicines contaminated with zinc phosphide, used as a rodenticide, could have led to the death of 13 women who underwent tubectomies.
While 12 of the 83 women, who were operated upon at Nemichand Jain Cancer and Research Centre at Pendari village of Takhatpur block on November 8, died, a protected Baiga tribe woman was the lone casualty at Pendra block, where around 56 women underwent surgeries at three different camps on November 10.
Over 130 women had fallen ill after the surgeries.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
